CXL Consortium Showcases First Public Demonstrations of Compute Express Link Technology at Supercomputing 2021

BEAVERTON, Ore.–(BUSINESS WIRE)–The CXL™ Consortium, an industry standards body dedicated to advancing Compute Express Link™ (CXL™) technology, will showcase growing momentum for CXL technology at Supercomputing (SC21), taking place at America’s Center in St. Louis, Missouri and virtually November 15-18. The CXL specification enables a high-speed, efficient interconnect between the CPU and platform enhancements and …

Ford Pro CEO Ted Cannis to Discuss Electrification, Commercial Vehicles, Digital Connectivity at Barclays Global Automotive and Mobility Tech Conference

DEARBORN, Mich.–(BUSINESS WIRE)–Ted Cannis, CEO of Ford Pro, Ford’s global vehicle services and distribution business focused on helping commercial customers improve performance, will participate in a fireside chat with autos analyst Brian Johnson at the upcoming Barclays Global Automotive and Mobility Tech Conference. The virtual event will take place on Thursday, Nov. 18, at 9:20 …

Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences

BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences: Jefferies London Healthcare Conference Presentation: Pre-recorded fireside chat will be made available on-demand beginning on Thursday, November 18th …

Olo to Present at RBC Capital Markets Global Technology, Internet, Media and Telecom Virtual Conference

NEW YORK–(BUSINESS WIRE)–Olo Inc. (NYSE:OLO), a leading on-demand commerce platform powering the restaurant industry’s digital transformation, today announced that Noah Glass, Founder and CEO, and Peter Benevides, CFO, will present at the RBC Capital Markets Global Technology, Internet, Media and Telecom Virtual Conference. Olo’s presentation is scheduled for Tuesday, November 16, 2021, at 2:40 p.m., …

OpRegen® Clinical Data Presented at 125th Annual American Academy of Ophthalmology Meeting by Michael S. Ip, M.D.

CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported updated interim results from a Phase 1/2a clinical study of its lead product candidate, OpRegen®, an investigational retinal pigment epithelium (“RPE”) cell transplant therapy currently in development for the treatment …

Digi International Named as CES 2022 Innovation Awards Honoree

HOPKINS, Minn.–(BUSINESS WIRE)–Digi International®, (NASDAQ: DGII, www.digi.com), a leading global provider of Internet of Things (IoT) connectivity products and services, today announced that it has been named a CES® 2022 Innovation Awards Honoree in the Smart Cities category for its TX64 5G/LTE-Advanced Cellular Router. This year’s CES Innovation Awards program received a record high number …

Asher Bio to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, today announced that company management will participate in the following upcoming investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference Craig Gibbs, Ph.D., Chief Executive Officer, will pre-record a corporate presentation, which will become available to registered …

Biodesix Announces Third Quarter 2021 Results and Highlights

BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the third quarter ended September 30, 2021 and provided a corporate update. “The third quarter was highlighted by the growth of our core lung diagnostics and biopharma service product …

UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments

PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat urothelial and specialty cancers, today announced financial results for the third quarter ended September 30, 2021, and provided an overview of the Company’s recent developments. “The third quarter of 2021 was one of continued progress at …

Butterfly Network Reports Third Quarter 2021 Financial Results

GUILFORD, Conn. & NEW YORK–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), an innovative digital health company that is working to democratize medical imaging and improve global health equity, today announced financial results for the quarter ended September 30, 2021, and provided a business update. Third Quarter 2021 Highlights: Reported revenue of $14.6 million for the …